S1PR5
Sphingosine 1-phosphate receptor 5
Also known as: Edg-8, EDG8, S1PR5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H228
- Gene
- S1PR5
- Ensembl
- ENSG00000180739
- Chromosome
- 19
- Canonical length
- 398 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
The lysosphingolipid sphingosine 1-phosphate (S1P) regulates cell proliferation, apoptosis, motility, and neurite retraction. Its actions may be both intracellular as a second messenger and extracellular as a receptor ligand. S1P and the structurally related lysolipid mediator lysophosphatidic acid (LPA) signal cells through a set of G protein-coupled receptors known as EDG receptors. Some EDG receptors (e.g., EDG1; MIM 601974) are S1P receptors; others (e.g., EDG2; MIM 602282) are LPA receptors.[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
398 residues, UniProt reviewed canonical sequence.
>Q9H228|S1PR5
1 MESGLLRPAP VSEVIVLHYN YTGKLRGARY QPGAGLRADA VVCLAVCAFI VLENLAVLLV
61 LGRHPRFHAP MFLLLGSLTL SDLLAGAAYA ANILLSGPLT LKLSPALWFA REGGVFVALT
121 ASVLSLLAIA LERSLTMARR GPAPVSSRGR TLAMAAAAWG VSLLLGLLPA LGWNCLGRLD
181 ACSTVLPLYA KAYVLFCVLA FVGILAAICA LYARIYCQVR ANARRLPARP GTAGTTSTRA
241 RRKPRSLALL RTLSVVLLAF VACWGPLFLL LLLDVACPAR TCPVLLQADP FLGLAMANSL
301 LNPIIYTLTN RDLRHALLRL VCCGRHSCGR DPSGSQQSAS AAEASGGLRR CLPPGLDGSF
361 SGSERSSPQR DGLDTSGSTG SPGAPTAART LVSEPAADLocalizationUniProt · AlphaFold · HPA
Whether an antibody against S1PR5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 48 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 48 nTPM
- midbrain: 35 nTPM
- hippocampal formation: 25 nTPM
- basal ganglia: 21 nTPM
- amygdala: 16 nTPM
- bone marrow: 15 nTPM
Single-cell type
- nk-cells: 82 nCPM
- oligodendrocytes: 25 nCPM
- esophageal basal cells: 23 nCPM
- submucosal glandular cells: 12 nCPM
- basal prostatic cells: 12 nCPM
- prostatic hillock cells: 11 nCPM
Immune cell
- gdT-cell: 300 nTPM
- MAIT T-cell: 185 nTPM
- memory CD8 T-cell: 145 nTPM
- naive CD8 T-cell: 109 nTPM
- total PBMC: 64 nTPM
- NK-cell: 44 nTPM
Brain region
- white matter: 108 nTPM
- medulla oblongata: 68 nTPM
- basal ganglia: 59 nTPM
- midbrain: 56 nTPM
- pons: 53 nTPM
- cerebellum: 53 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.03
- gnomAD pLI
- 0.16
- gnomAD missense Z
- 1.45
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- G protein-coupled receptor, rhodopsin-like
- Sphingosine 1-phosphate receptor
- GPCR, rhodopsin-like, 7TM
- 7 transmembrane receptor (rhodopsin family)
- EDG-8 sphingosine 1-phosphate receptor
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads S1PR5 as an antibody target. Whether an autoantibody or antibody against S1PR5 could matter depends on whether native S1PR5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
S1PR5 is annotated at the cell surface, where native S1PR5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label S1PR5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...